Related Experiment Video

Updated: Jun 12, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human

X Shang1, S A Vasudevan, Y Yu

  • 1Texas Children's Cancer Center, Department of Pediatrics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Oncogene
|June 22, 2010
PubMed

Insights

Dual-specificity phosphatase 26 (DUSP26) promotes chemoresistance in neuroblastoma by deactivating the tumor suppressor p53. Inhibiting DUSP26 may enhance treatment effectiveness for this pediatric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Chemoresistance is a significant challenge in neuroblastoma treatment, leading to poor patient outcomes.
  • Dual-specificity phosphatase 26 (DUSP26), also known as mitogen-activated protein kinase phosphatase-8, is investigated for its role in cancer.

Purpose of the Study:

  • To determine the expression and function of DUSP26 in human neuroblastoma.
  • To elucidate the mechanism by which DUSP26 influences chemoresistance, particularly to doxorubicin.

Main Methods:

  • Assessed DUSP26 expression in neuroblastoma cell lines and tissue samples.
  • Utilized cell line models (IMR-32, SK-N-SH) to study the effects of DUSP26 inhibition and overexpression on doxorubicin-induced apoptosis.
  • Performed in vitro and in vivo assays to confirm DUSP26 binding and dephosphorylation of p53.

Main Results:

  • DUSP26 is expressed in most neuroblastoma cell lines and tissues.
  • DUSP26 promotes doxorubicin resistance by dephosphorylating p53 at Ser20 and Ser37, thereby downregulating its tumor suppressor activity.
  • Inhibition of DUSP26 increased apoptosis and expression of p53-related proteins (p21, Puma, Bax), while its overexpression decreased these effects.

Conclusions:

  • DUSP26 acts as a p53 phosphatase, suppressing p53 activity in response to genotoxic stress in neuroblastoma.
  • Targeting DUSP26 could be a novel therapeutic strategy to overcome chemoresistance and improve outcomes in neuroblastoma.

More Related Videos

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...